Competition in the German pharmacy market: an empirical analysis

BACKGROUND: Pharmaceutical products are an important component of expenditure on public health insurance in the Federal Republic of Germany. For years, German policy makers have regulated public pharmacies in order to limit the increase in costs. One reform has followed another, main objective being...

Descripción completa

Detalles Bibliográficos
Autores principales: Heinsohn, Jörg G, Flessa, Steffen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3856528/
https://www.ncbi.nlm.nih.gov/pubmed/24112461
http://dx.doi.org/10.1186/1472-6963-13-407

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3856528/
https://www.ncbi.nlm.nih.gov/pubmed/24112461
http://dx.doi.org/10.1186/1472-6963-13-407

Ejemplares similares